Artificial Intelligence System for Early Warning of Adverse Events in Acute Myocardial Infarction
AIEWAEAMI
1 other identifier
observational
1,400
1 country
1
Brief Summary
The goal of this observational study is to learn about the effectiveness of an artificial intelligence-based early warning system for predicting adverse events in patients with acute myocardial infarction (AMI). The main question it aims to answer is: Does an AI-based early warning system improve the assessment and prediction of adverse events across the full course of AMI care (from prevention to diagnosis, treatment, and rehabilitation)? Participants who are receiving routine medical care for AMI in tertiary hospitals will have their multimodal medical data (clinical records, diagnostic tests, imaging, treatment pathways) collected and analyzed. Data will be integrated using innovative cross-modal representation methods and predictive models. The study will follow patients during their hospital stay and subsequent clinical follow-up to evaluate the feasibility, accuracy, and clinical value of the AI-based early warning system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 26, 2022
CompletedFirst Submitted
Initial submission to the registry
August 22, 2025
CompletedFirst Posted
Study publicly available on registry
August 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
August 24, 2025
August 1, 2025
4.1 years
August 22, 2025
August 22, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
MACCE
Cardiac death All-cause mortality Malignant arrhythmia Non-fatal recurrent myocardial infarction Non-fatal stroke Unplanned repeat revascularization Rehospitalization for heart failure
1-3 years
Study Arms (2)
BFH
group1
AZH
group2
Eligibility Criteria
1. Retrospective Study Population: Data were obtained from the Cardiovascular Center Database (CBDBank) of Beijing Friendship Hospital. CBDBank is a continuously collected sample dataset of patients with acute coronary syndrome since January 2013. A total of 1,000 patients with acute myocardial infarction admitted to Beijing Friendship Hospital, Capital Medical University, from January 2017 to December 2019 were included in the retrospective cohort. After discharge, all patients received scheduled telephone follow-ups at 1 month, 3 months, 6 months, and annually thereafter, with continuous follow-up for 3 years. 2. Prospective Study Population: A total of 800 patients with acute myocardial infarction admitted to the Cardiovascular Center of Beijing Friendship Hospital from July 2023 to July 2026 will be enrolled in the prospective cohort. Randomization will be performed using random codes, and prognosis prediction will be conducted using either the predictive system or traditional met
You may qualify if:
- \. Hospitalized patients who meet the diagnostic criteria for acute myocardial infarction. 2. Patients who agree to participate and sign the informed consent form.
You may not qualify if:
- \. Patients with terminal malignant tumors and an expected survival time of less than 3 months. 2. Patients with complete disability and inability to communicate. 3. Patients unable to comply with follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hui Chenlead
Study Sites (1)
Beijing Friendship Hospital
Beijing, 100050, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- PHD
Study Record Dates
First Submitted
August 22, 2025
First Posted
August 24, 2025
Study Start
November 26, 2022
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
August 24, 2025
Record last verified: 2025-08